Breaks Categories: News

FridayNov 13, 2020 12:59 pm

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Clinical Trial for CBD-Based Therapeutic Candidate – CaniDermRx

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced its initiation of an exploratory clinical study of CaniDermRx. Jupiter’s prescription topical cream candidate, CaniDermRx, combines CBD and aspartame as its active ingredients in the treatment of first degree burns. While, to Jupiter's knowledge, no double-blind, randomized controlled study has demonstrated efficacy of a CBD-aspartame product in the treatment of burns, CaniDermRx may be effective in this indication based on its dual mechanisms of action. “We are pleased to commence this clinical study in what is now our second indication for our CBD-based…

Continue Reading

FridayNov 13, 2020 12:53 pm

NetworkNewsBreaks – Appreciated Media Holdings Inc. (TSXV: AMH) (OTCQB: AMEFF) Announces Strategic Board Appointments

Appreciated Media Holdings (TSXV: AMH) (OTCQB: AMEFF) today announced the appointment of Michael Walker and Andy Lyon to its board of directors, subject to the approval of the TSX Venture Exchange. Walker currently serves as president of Cloud Ten Pictures and holds a well-rounded knowledge base and a wealth of experience in all aspects of the film and television industry. Lyon is a highly regarded UK-based executive with almost 30 years of experience in the film distribution business. He currently serves as the managing director of 101 Films Limited. To view the full press release, visit https://nnw.fm/n1Oz7 About Appreciated Media…

Continue Reading

FridayNov 13, 2020 12:26 pm

NetworkNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Q3 2020 Results, Operational Update

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a Vancouver, Canada-based company focused on manufacturing pharmaceutical-grade cannabinoids via synthetic biology, has released its financial and operating results for the three and nine months ended September 30, 2020. According to the update, Willow Biosciences reported significant advancement in its operations and strong liquidity. The update reads, “The third quarter represented another significant move forward for us, as we completed our first pilot campaign as part of our final development stage before we begin commercial production, which is anticipated to commence around the middle of 2021. From the pilot, and with our well-advanced downstream…

Continue Reading

FridayNov 13, 2020 11:59 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) to Host Teleconference to Discuss Q2 2021 Results

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced its plans to host a teleconference with investors and analysts to review fiscal second-quarter 2021 financial results. President and CEO Richard Wright and Chief Financial Officer David Guarino will host the call at 5:00 PM Eastern Time on Monday, Nov. 16, 2020. In addition, the company will issue a press release outlining its financial results and outlook after the market close on Nov. 16, 2020. Interested parties may join the teleconference by dialing 877-407-3088 (U.S. and…

Continue Reading

FridayNov 13, 2020 11:55 am

NetworkNewsBreaks – RIWI Corp. (TSX.V: RIWI) (OTC: RWCRF) Predicted Tight Election Race; Releases Election Reports

RIWI Corp. (TSX.V: RIWI) (OTC: RWCRF), a global trend-tracking and prediction technology firm, has released election reports that the company had prepared for American, British and Asian finance clients since Sept. 8, 2020. Based on its reports, the company had predicted close numbers for the U.S. presidential race. RIWI’s predictions were in direct opposition with most public polling and media forecasts, which were predicting a significant victory for Joe Biden, former U.S. vice president. In fact, RIWI’s final client report, which was finalized at 10 a.m. ET on Nov. 2, predicted a tight race between Biden and current U.S. President…

Continue Reading

FridayNov 13, 2020 11:29 am

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q3 2020 Results, Provides Corporate Update

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products intended to provide treatment for and improve the survival and/or quality of life for patients with unmet medical needs or no alternative treatment, on Thursday released its financial results for the third quarter of 2020. In addition, Processa provided a business update via conference call, for which the replay may be accessed at https://nnw.fm/D1KVg or by dialing 877-481-4010 (Toll-free) or 919-882-2331 (International) and entering replay passcode: 38528. “The third quarter was a period of tremendous value creation. Over that time, we in-licensed important clinical drug…

Continue Reading

FridayNov 13, 2020 11:14 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Q3 2020 Results

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, on Thursday announced financial results for the third quarter ended September 30, 2020. According to the update, Foresight ended the quarter with $14.5 million in cash and short-term deposits, GAAP net loss of $11.4 million and non-GAAP net loss for the same period of $10.5 million. “Foresight continued to demonstrate steady progress in the third quarter, as we established new partnerships with influential players in Europe, Japan and China,” said Haim Siboni, CEO of Foresight. “We are confident that our new relationships with leading companies such as…

Continue Reading

FridayNov 13, 2020 10:31 am

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Q2 Results, Provides Update on CNS Pipeline and Business Progress

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today reported its financial results for the fiscal 2021 second quarter ended September 30, 2020. In addition, the company provided an update on its CNS pipeline and business progress. “We see a significant rise in mental health concerns as the global COVID-19 pandemic continues to impact the daily lives of millions of individuals. We are committed to developing innovative therapies that provide relief to those suffering from anxiety and depression, and we are working diligently towards that goal,” said VistaGen…

Continue Reading

FridayNov 13, 2020 9:36 am

NetworkNewsBreaks – IBN’s Jonathan Keim Featured in ‘The Digital Evolution’ Episode on DojoLIVE!

InvestorBrandNetwork’s (“IBN”) Communications Director, Jonathan Keim, was featured in a recent episode of DojoLIVE! In the episode, titled “The Digital Evolution: Maximizing Your Impact,” Keim joined hosts Tullio Siragusa, Kim Lantis and Carlos Ponce to discuss wide ranging ideas and strategies to maximize impression, increase influence and expand one’s presence across the digital landscape. “Some of the different things that have been really effective for us. . . I mentioned newsletters, and really anything that would be a subscription format, whether it’s podcast subscribers, text blasting,” Keim said, discussing a list of ideas to increase digital presence. This insight is…

Continue Reading

ThursdayNov 12, 2020 3:05 pm

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Board Appointment of Dwight Duncan

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, on Tuesday announced the appointment of Dwight Duncan to its board of directors. Duncan serves as a senior strategic advisor at McMillan LLP, a large Canadian full-service business law firm. He also serves as a principal of McMillan Vantage, McMillan LLP’s wholly owned public policy advisory firm, and chairs the board of directors of the Windsor Detroit Bridge Authority, the federal crown corporation overseeing the construction and operation of the $5.7 billion Gordie Howe International Bridge. “We are pleased to welcome Dwight Duncan…

Continue Reading